Home » Topics » BioWorld Science

BioWorld Science
RSS

First COVID-19 patient treated under emergency use IND with Stemedica's itMSCs

April 21, 2020

Promising topline data for Xeris' novel intramuscular injection formulation of diazepam

April 21, 2020

Alexion to initiate global phase III study of Ultomiris in severe COVID-19

April 21, 2020

Long noncoding RNA has sex-specific role in depression

April 21, 2020

FDA clears IND to initiate phase I/II study of PRGN-2009

April 21, 2020

Phase III CheckMate-9ER study of Opdivo and Cabometyx in RCC meets primary endpoint

April 21, 2020

Pivotal CheckMate-743 trial of Opdivo plus Yervoy in MPM meets primary endpoint

April 21, 2020

Anixa and OntoChem collaborate to develop novel antiviral therapies against COVID-19

April 21, 2020

CAR macrophages with directed antitumor phagocytic activity for cancer immunotherapy

April 21, 2020

A paracrine interaction between breast cancer cells and MAFs promotes metastatic progression

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...